nodes	percent_of_prediction	percent_of_DWPC	metapath
Trandolapril—CES1—Rufinamide—epilepsy syndrome	0.288	1	CbGbCtD
Trandolapril—Nateglinide—Lacosamide—epilepsy syndrome	0.202	0.513	CrCrCtD
Trandolapril—Aspartame—Lacosamide—epilepsy syndrome	0.191	0.487	CrCrCtD
Trandolapril—ACE—forelimb—epilepsy syndrome	0.00342	0.187	CbGeAlD
Trandolapril—ACE—autonomic nervous system—epilepsy syndrome	0.00332	0.182	CbGeAlD
Trandolapril—ACE—Metabolism of Angiotensinogen to Angiotensins—ATP6AP2—epilepsy syndrome	0.00256	0.0442	CbGpPWpGaD
Trandolapril—ACE—ACE Inhibitor Pathway—ATP6AP2—epilepsy syndrome	0.00244	0.0421	CbGpPWpGaD
Trandolapril—CES1—Irinotecan Pathway—ABCC2—epilepsy syndrome	0.00213	0.0367	CbGpPWpGaD
Trandolapril—ACE—ACE Inhibitor Pathway—BDKRB1—epilepsy syndrome	0.00195	0.0337	CbGpPWpGaD
Trandolapril—CES1—Fluoropyrimidine Activity—UPB1—epilepsy syndrome	0.00186	0.0322	CbGpPWpGaD
Trandolapril—ACE—ganglion—epilepsy syndrome	0.00185	0.101	CbGeAlD
Trandolapril—CES1—Irinotecan Pathway—ABCG2—epilepsy syndrome	0.00181	0.0312	CbGpPWpGaD
Trandolapril—CES1—Irinotecan Pathway—BCHE—epilepsy syndrome	0.0015	0.0258	CbGpPWpGaD
Trandolapril—ACE—ACE Inhibitor Pathway—BDKRB2—epilepsy syndrome	0.00135	0.0233	CbGpPWpGaD
Trandolapril—CES1—Fluoropyrimidine Activity—ABCG2—epilepsy syndrome	0.00091	0.0157	CbGpPWpGaD
Trandolapril—ACE—Metabolism of Angiotensinogen to Angiotensins—AGT—epilepsy syndrome	0.000903	0.0156	CbGpPWpGaD
Trandolapril—Aspartame—TRPV1—epilepsy syndrome	0.000887	0.236	CrCbGaD
Trandolapril—ACE—ACE Inhibitor Pathway—AGT—epilepsy syndrome	0.000861	0.0149	CbGpPWpGaD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A5—epilepsy syndrome	0.000787	0.0136	CbGpPWpGaD
Trandolapril—ACE—forebrain—epilepsy syndrome	0.000775	0.0424	CbGeAlD
Trandolapril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC1A1—epilepsy syndrome	0.000768	0.0133	CbGpPWpGaD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A5—epilepsy syndrome	0.000731	0.0126	CbGpPWpGaD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A10—epilepsy syndrome	0.00072	0.0124	CbGpPWpGaD
Trandolapril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC1A1—epilepsy syndrome	0.000713	0.0123	CbGpPWpGaD
Trandolapril—ACE—telencephalon—epilepsy syndrome	0.000712	0.039	CbGeAlD
Trandolapril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC17A7—epilepsy syndrome	0.000702	0.0121	CbGpPWpGaD
Trandolapril—CES1—Fluoropyrimidine Activity—SMUG1—epilepsy syndrome	0.000697	0.012	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—ATP6AP2—epilepsy syndrome	0.000674	0.0116	CbGpPWpGaD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A10—epilepsy syndrome	0.000668	0.0115	CbGpPWpGaD
Trandolapril—CES1—head—epilepsy syndrome	0.000667	0.0365	CbGeAlD
Trandolapril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC1A2—epilepsy syndrome	0.000653	0.0113	CbGpPWpGaD
Trandolapril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC17A7—epilepsy syndrome	0.000652	0.0113	CbGpPWpGaD
Trandolapril—Mitiglinide—KCNJ11—epilepsy syndrome	0.000641	0.171	CrCbGaD
Trandolapril—CES1—nervous system—epilepsy syndrome	0.000632	0.0346	CbGeAlD
Trandolapril—SLC15A2—telencephalon—epilepsy syndrome	0.000621	0.034	CbGeAlD
Trandolapril—CES1—NRF2 pathway—SLC6A8—epilepsy syndrome	0.00062	0.0107	CbGpPWpGaD
Trandolapril—CES1—central nervous system—epilepsy syndrome	0.000608	0.0333	CbGeAlD
Trandolapril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC1A2—epilepsy syndrome	0.000606	0.0105	CbGpPWpGaD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A6—epilepsy syndrome	0.000597	0.0103	CbGpPWpGaD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A2—epilepsy syndrome	0.000597	0.0103	CbGpPWpGaD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A3—epilepsy syndrome	0.000569	0.00982	CbGpPWpGaD
Trandolapril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC1A3—epilepsy syndrome	0.000555	0.00958	CbGpPWpGaD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A2—epilepsy syndrome	0.000554	0.00956	CbGpPWpGaD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A6—epilepsy syndrome	0.000554	0.00956	CbGpPWpGaD
Trandolapril—Enalapril—SLCO1A2—epilepsy syndrome	0.000541	0.144	CrCbGaD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A3—epilepsy syndrome	0.000528	0.00912	CbGpPWpGaD
Trandolapril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC1A3—epilepsy syndrome	0.000515	0.00889	CbGpPWpGaD
Trandolapril—ACE—spinal cord—epilepsy syndrome	0.000499	0.0273	CbGeAlD
Trandolapril—SLC15A2—medulla oblongata—epilepsy syndrome	0.000488	0.0267	CbGeAlD
Trandolapril—CES1—brain—epilepsy syndrome	0.000483	0.0264	CbGeAlD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A1—epilepsy syndrome	0.000452	0.0078	CbGpPWpGaD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—epilepsy syndrome	0.000452	0.0078	CbGpPWpGaD
Trandolapril—SLC15A2—midbrain—epilepsy syndrome	0.000446	0.0244	CbGeAlD
Trandolapril—ACE—head—epilepsy syndrome	0.000444	0.0243	CbGeAlD
Trandolapril—SLC15A2—spinal cord—epilepsy syndrome	0.000435	0.0238	CbGeAlD
Trandolapril—ACE—nervous system—epilepsy syndrome	0.000421	0.023	CbGeAlD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—epilepsy syndrome	0.00042	0.00724	CbGpPWpGaD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A1—epilepsy syndrome	0.00042	0.00724	CbGpPWpGaD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A7—epilepsy syndrome	0.000414	0.00714	CbGpPWpGaD
Trandolapril—ACE—central nervous system—epilepsy syndrome	0.000405	0.0221	CbGeAlD
Trandolapril—CES1—NRF2 pathway—TXNRD1—epilepsy syndrome	0.000387	0.00668	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—BCHE—epilepsy syndrome	0.000387	0.00668	CbGpPWpGaD
Trandolapril—SLC15A2—head—epilepsy syndrome	0.000387	0.0212	CbGeAlD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—epilepsy syndrome	0.000385	0.00664	CbGpPWpGaD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A7—epilepsy syndrome	0.000384	0.00662	CbGpPWpGaD
Trandolapril—Perindopril—BCHE—epilepsy syndrome	0.000375	0.1	CrCbGaD
Trandolapril—SLC15A2—nervous system—epilepsy syndrome	0.000367	0.0201	CbGeAlD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—epilepsy syndrome	0.000357	0.00616	CbGpPWpGaD
Trandolapril—SLC15A2—central nervous system—epilepsy syndrome	0.000353	0.0193	CbGeAlD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC12A5—epilepsy syndrome	0.000352	0.00607	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC35A3—epilepsy syndrome	0.000352	0.00607	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC35A2—epilepsy syndrome	0.000352	0.00607	CbGpPWpGaD
Trandolapril—SLC15A2—cerebellum—epilepsy syndrome	0.000345	0.0189	CbGeAlD
Trandolapril—ACE—Metabolism of proteins—VDAC1—epilepsy syndrome	0.000344	0.00593	CbGpPWpGaD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A1—epilepsy syndrome	0.000339	0.00584	CbGpPWpGaD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—epilepsy syndrome	0.000327	0.00564	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC35A3—epilepsy syndrome	0.000327	0.00564	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC12A5—epilepsy syndrome	0.000327	0.00564	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC35A2—epilepsy syndrome	0.000327	0.00564	CbGpPWpGaD
Trandolapril—Nateglinide—KCNJ11—epilepsy syndrome	0.000327	0.0871	CrCbGaD
Trandolapril—CES1—NRF2 pathway—ABCC2—epilepsy syndrome	0.000326	0.00562	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC4A10—epilepsy syndrome	0.000322	0.00555	CbGpPWpGaD
Trandolapril—ACE—brain—epilepsy syndrome	0.000321	0.0176	CbGeAlD
Trandolapril—Ramipril—BCHE—epilepsy syndrome	0.00032	0.0854	CrCbGaD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A1—epilepsy syndrome	0.000314	0.00542	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—SIRT1—epilepsy syndrome	0.000305	0.00526	CbGpPWpGaD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—epilepsy syndrome	0.000303	0.00524	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—SLC6A1—epilepsy syndrome	0.000303	0.00523	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC4A10—epilepsy syndrome	0.000299	0.00515	CbGpPWpGaD
Trandolapril—SLC15A2—brain—epilepsy syndrome	0.00028	0.0153	CbGeAlD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLCO1A2—epilepsy syndrome	0.000267	0.0046	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC8A2—epilepsy syndrome	0.000267	0.0046	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC9A6—epilepsy syndrome	0.000267	0.0046	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—PIGT—epilepsy syndrome	0.00026	0.00449	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—PIGN—epilepsy syndrome	0.00026	0.00449	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC8A3—epilepsy syndrome	0.000254	0.00439	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC8A2—epilepsy syndrome	0.000248	0.00427	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLCO1A2—epilepsy syndrome	0.000248	0.00427	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC9A6—epilepsy syndrome	0.000248	0.00427	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—PLAU—epilepsy syndrome	0.000244	0.00421	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—SLC6A4—epilepsy syndrome	0.000242	0.00418	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—GOSR2—epilepsy syndrome	0.000238	0.00411	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—AGT—epilepsy syndrome	0.000238	0.0041	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC8A3—epilepsy syndrome	0.000236	0.00407	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—ATM—epilepsy syndrome	0.000231	0.00399	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—ERN1—epilepsy syndrome	0.000221	0.00382	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—SLC2A1—epilepsy syndrome	0.000219	0.00378	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	0.000207	0.00358	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—HBEGF—epilepsy syndrome	0.000206	0.00355	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	0.000202	0.00349	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	0.000202	0.00349	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.000201	0.00346	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.000201	0.00346	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—POMC—epilepsy syndrome	0.0002	0.00345	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	0.000192	0.00332	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	0.000188	0.00324	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	0.000188	0.00324	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.000186	0.00321	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.000186	0.00321	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	0.000185	0.00319	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—NEU1—epilepsy syndrome	0.00018	0.00311	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—EIF2AK3—epilepsy syndrome	0.00018	0.00311	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—HMOX1—epilepsy syndrome	0.00018	0.00311	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.000179	0.00309	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.000179	0.00309	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.000179	0.00309	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	0.000172	0.00297	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	0.000172	0.00296	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—TPP1—epilepsy syndrome	0.000168	0.0029	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—PIGA—epilepsy syndrome	0.000168	0.0029	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.000166	0.00286	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.000166	0.00286	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.000166	0.00286	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.000164	0.00282	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	0.000159	0.00275	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—EIF2B5—epilepsy syndrome	0.000158	0.00272	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.000152	0.00262	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	0.000151	0.00261	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—ADD1—epilepsy syndrome	0.00015	0.00258	CbGpPWpGaD
Trandolapril—Perindopril—ABCB1—epilepsy syndrome	0.000147	0.0392	CrCbGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	0.000146	0.00252	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000143	0.00247	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	0.00014	0.00242	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—ST3GAL3—epilepsy syndrome	0.00014	0.00241	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	0.000136	0.00234	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000136	0.00234	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000136	0.00234	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000136	0.00234	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—ST3GAL5—epilepsy syndrome	0.000134	0.00231	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000133	0.00229	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	0.00013	0.00225	CbGpPWpGaD
Trandolapril—Cilazapril—ABCB1—epilepsy syndrome	0.00013	0.0346	CrCbGaD
Trandolapril—Lisinopril—ABCB1—epilepsy syndrome	0.00013	0.0346	CrCbGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000129	0.00223	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000129	0.00223	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—ATP6AP2—epilepsy syndrome	0.000127	0.00219	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000126	0.00217	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000126	0.00217	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000126	0.00217	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	0.000121	0.00209	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.00012	0.00207	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.00012	0.00207	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.000105	0.00182	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000103	0.00177	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000103	0.00177	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	9.8e-05	0.00169	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	9.78e-05	0.00169	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	9.53e-05	0.00164	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	9.53e-05	0.00164	CbGpPWpGaD
Trandolapril—Enalapril—ABCB1—epilepsy syndrome	9.51e-05	0.0254	CrCbGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	9.42e-05	0.00162	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	9.39e-05	0.00162	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	9.39e-05	0.00162	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	9.39e-05	0.00162	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	9.39e-05	0.00162	CbGpPWpGaD
Trandolapril—Nateglinide—CYP2D6—epilepsy syndrome	9.1e-05	0.0242	CrCbGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	9.09e-05	0.00157	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	8.74e-05	0.00151	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	8.73e-05	0.00151	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	8.72e-05	0.0015	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	8.72e-05	0.0015	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	8.72e-05	0.0015	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	8.72e-05	0.0015	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—EIF2S1—epilepsy syndrome	8.59e-05	0.00148	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—ACTB—epilepsy syndrome	8.48e-05	0.00146	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	8.33e-05	0.00144	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	8.21e-05	0.00142	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	8.1e-05	0.0014	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	7.99e-05	0.00138	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	7.73e-05	0.00133	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	7.69e-05	0.00133	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	7.68e-05	0.00132	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	7.62e-05	0.00132	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	7.43e-05	0.00128	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	7.43e-05	0.00128	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	7.41e-05	0.00128	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—BCHE—epilepsy syndrome	7.3e-05	0.00126	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	7.14e-05	0.00123	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	7.12e-05	0.00123	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	7.12e-05	0.00123	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	6.89e-05	0.00119	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	6.89e-05	0.00119	CbGpPWpGaD
Trandolapril—Nateglinide—ALB—epilepsy syndrome	6.81e-05	0.0181	CrCbGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	6.62e-05	0.00114	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	6.61e-05	0.00114	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—PLAUR—epilepsy syndrome	6.35e-05	0.0011	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	6.14e-05	0.00106	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	6.05e-05	0.00104	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	5.9e-05	0.00102	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	5.62e-05	0.000969	CbGpPWpGaD
Trandolapril—Pruritus—Oxcarbazepine—epilepsy syndrome	5.58e-05	0.000234	CcSEcCtD
Trandolapril—Hypersensitivity—Carbamazepine—epilepsy syndrome	5.58e-05	0.000234	CcSEcCtD
Trandolapril—Headache—Vigabatrin—epilepsy syndrome	5.56e-05	0.000233	CcSEcCtD
Trandolapril—Vomiting—Diazepam—epilepsy syndrome	5.56e-05	0.000233	CcSEcCtD
Trandolapril—Anorexia—Valproic Acid—epilepsy syndrome	5.54e-05	0.000232	CcSEcCtD
Trandolapril—Rash—Diazepam—epilepsy syndrome	5.51e-05	0.000231	CcSEcCtD
Trandolapril—Dermatitis—Diazepam—epilepsy syndrome	5.51e-05	0.000231	CcSEcCtD
Trandolapril—Visual impairment—Topiramate—epilepsy syndrome	5.5e-05	0.00023	CcSEcCtD
Trandolapril—Myalgia—Pregabalin—epilepsy syndrome	5.48e-05	0.00023	CcSEcCtD
Trandolapril—Chest pain—Pregabalin—epilepsy syndrome	5.48e-05	0.00023	CcSEcCtD
Trandolapril—Arthralgia—Pregabalin—epilepsy syndrome	5.48e-05	0.00023	CcSEcCtD
Trandolapril—Ill-defined disorder—Gabapentin—epilepsy syndrome	5.48e-05	0.00023	CcSEcCtD
Trandolapril—Dizziness—Zonisamide—epilepsy syndrome	5.48e-05	0.000229	CcSEcCtD
Trandolapril—Headache—Diazepam—epilepsy syndrome	5.48e-05	0.000229	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	5.47e-05	0.000945	CbGpPWpGaD
Trandolapril—Anxiety—Pregabalin—epilepsy syndrome	5.46e-05	0.000229	CcSEcCtD
Trandolapril—Diarrhoea—Clonazepam—epilepsy syndrome	5.46e-05	0.000229	CcSEcCtD
Trandolapril—Anaemia—Gabapentin—epilepsy syndrome	5.46e-05	0.000229	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	5.44e-05	0.000228	CcSEcCtD
Trandolapril—Hypotension—Valproic Acid—epilepsy syndrome	5.43e-05	0.000228	CcSEcCtD
Trandolapril—Asthenia—Carbamazepine—epilepsy syndrome	5.43e-05	0.000228	CcSEcCtD
Trandolapril—Agitation—Gabapentin—epilepsy syndrome	5.43e-05	0.000227	CcSEcCtD
Trandolapril—Diarrhoea—Phenytoin—epilepsy syndrome	5.43e-05	0.000227	CcSEcCtD
Trandolapril—Discomfort—Pregabalin—epilepsy syndrome	5.42e-05	0.000227	CcSEcCtD
Trandolapril—Nausea—Fosphenytoin—epilepsy syndrome	5.41e-05	0.000227	CcSEcCtD
Trandolapril—Diarrhoea—Oxcarbazepine—epilepsy syndrome	5.4e-05	0.000226	CcSEcCtD
Trandolapril—Erythema multiforme—Topiramate—epilepsy syndrome	5.4e-05	0.000226	CcSEcCtD
Trandolapril—Angioedema—Gabapentin—epilepsy syndrome	5.4e-05	0.000226	CcSEcCtD
Trandolapril—Hypersensitivity—Lamotrigine—epilepsy syndrome	5.39e-05	0.000226	CcSEcCtD
Trandolapril—Vomiting—Felbamate—epilepsy syndrome	5.38e-05	0.000225	CcSEcCtD
Trandolapril—Dry mouth—Pregabalin—epilepsy syndrome	5.36e-05	0.000225	CcSEcCtD
Trandolapril—Pruritus—Carbamazepine—epilepsy syndrome	5.36e-05	0.000224	CcSEcCtD
Trandolapril—Rash—Felbamate—epilepsy syndrome	5.34e-05	0.000224	CcSEcCtD
Trandolapril—Eye disorder—Topiramate—epilepsy syndrome	5.33e-05	0.000223	CcSEcCtD
Trandolapril—Dermatitis—Felbamate—epilepsy syndrome	5.33e-05	0.000223	CcSEcCtD
Trandolapril—Malaise—Gabapentin—epilepsy syndrome	5.33e-05	0.000223	CcSEcCtD
Trandolapril—Tinnitus—Topiramate—epilepsy syndrome	5.32e-05	0.000223	CcSEcCtD
Trandolapril—Vertigo—Gabapentin—epilepsy syndrome	5.31e-05	0.000222	CcSEcCtD
Trandolapril—Headache—Felbamate—epilepsy syndrome	5.3e-05	0.000222	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	5.3e-05	0.000222	CcSEcCtD
Trandolapril—Cardiac disorder—Topiramate—epilepsy syndrome	5.3e-05	0.000222	CcSEcCtD
Trandolapril—Flushing—Topiramate—epilepsy syndrome	5.3e-05	0.000222	CcSEcCtD
Trandolapril—Syncope—Gabapentin—epilepsy syndrome	5.3e-05	0.000222	CcSEcCtD
Trandolapril—Leukopenia—Gabapentin—epilepsy syndrome	5.29e-05	0.000221	CcSEcCtD
Trandolapril—Dizziness—Clonazepam—epilepsy syndrome	5.28e-05	0.000221	CcSEcCtD
Trandolapril—Nausea—Vigabatrin—epilepsy syndrome	5.28e-05	0.000221	CcSEcCtD
Trandolapril—Vomiting—Zonisamide—epilepsy syndrome	5.27e-05	0.000221	CcSEcCtD
Trandolapril—Insomnia—Valproic Acid—epilepsy syndrome	5.26e-05	0.00022	CcSEcCtD
Trandolapril—Oedema—Pregabalin—epilepsy syndrome	5.26e-05	0.00022	CcSEcCtD
Trandolapril—Asthenia—Lamotrigine—epilepsy syndrome	5.25e-05	0.00022	CcSEcCtD
Trandolapril—Dizziness—Phenytoin—epilepsy syndrome	5.24e-05	0.00022	CcSEcCtD
Trandolapril—Rash—Zonisamide—epilepsy syndrome	5.22e-05	0.000219	CcSEcCtD
Trandolapril—Infection—Pregabalin—epilepsy syndrome	5.22e-05	0.000219	CcSEcCtD
Trandolapril—Paraesthesia—Valproic Acid—epilepsy syndrome	5.22e-05	0.000219	CcSEcCtD
Trandolapril—Palpitations—Gabapentin—epilepsy syndrome	5.22e-05	0.000219	CcSEcCtD
Trandolapril—Dermatitis—Zonisamide—epilepsy syndrome	5.22e-05	0.000219	CcSEcCtD
Trandolapril—Dizziness—Oxcarbazepine—epilepsy syndrome	5.22e-05	0.000219	CcSEcCtD
Trandolapril—Nausea—Diazepam—epilepsy syndrome	5.19e-05	0.000218	CcSEcCtD
Trandolapril—Loss of consciousness—Gabapentin—epilepsy syndrome	5.19e-05	0.000217	CcSEcCtD
Trandolapril—Headache—Zonisamide—epilepsy syndrome	5.19e-05	0.000217	CcSEcCtD
Trandolapril—Dyspnoea—Valproic Acid—epilepsy syndrome	5.18e-05	0.000217	CcSEcCtD
Trandolapril—Diarrhoea—Carbamazepine—epilepsy syndrome	5.18e-05	0.000217	CcSEcCtD
Trandolapril—Angiopathy—Topiramate—epilepsy syndrome	5.18e-05	0.000217	CcSEcCtD
Trandolapril—Pruritus—Lamotrigine—epilepsy syndrome	5.18e-05	0.000217	CcSEcCtD
Trandolapril—Shock—Pregabalin—epilepsy syndrome	5.17e-05	0.000217	CcSEcCtD
Trandolapril—Somnolence—Valproic Acid—epilepsy syndrome	5.17e-05	0.000217	CcSEcCtD
Trandolapril—Immune system disorder—Topiramate—epilepsy syndrome	5.15e-05	0.000216	CcSEcCtD
Trandolapril—Nervous system disorder—Pregabalin—epilepsy syndrome	5.15e-05	0.000216	CcSEcCtD
Trandolapril—Cough—Gabapentin—epilepsy syndrome	5.15e-05	0.000216	CcSEcCtD
Trandolapril—Thrombocytopenia—Pregabalin—epilepsy syndrome	5.15e-05	0.000216	CcSEcCtD
Trandolapril—Mediastinal disorder—Topiramate—epilepsy syndrome	5.14e-05	0.000215	CcSEcCtD
Trandolapril—Tachycardia—Pregabalin—epilepsy syndrome	5.13e-05	0.000215	CcSEcCtD
Trandolapril—Dyspepsia—Valproic Acid—epilepsy syndrome	5.12e-05	0.000214	CcSEcCtD
Trandolapril—Skin disorder—Pregabalin—epilepsy syndrome	5.1e-05	0.000214	CcSEcCtD
Trandolapril—Hyperhidrosis—Pregabalin—epilepsy syndrome	5.08e-05	0.000213	CcSEcCtD
Trandolapril—Vomiting—Clonazepam—epilepsy syndrome	5.08e-05	0.000213	CcSEcCtD
Trandolapril—Decreased appetite—Valproic Acid—epilepsy syndrome	5.05e-05	0.000212	CcSEcCtD
Trandolapril—Alopecia—Topiramate—epilepsy syndrome	5.04e-05	0.000211	CcSEcCtD
Trandolapril—Vomiting—Phenytoin—epilepsy syndrome	5.04e-05	0.000211	CcSEcCtD
Trandolapril—Rash—Clonazepam—epilepsy syndrome	5.03e-05	0.000211	CcSEcCtD
Trandolapril—Dermatitis—Clonazepam—epilepsy syndrome	5.03e-05	0.000211	CcSEcCtD
Trandolapril—Arthralgia—Gabapentin—epilepsy syndrome	5.03e-05	0.000211	CcSEcCtD
Trandolapril—Myalgia—Gabapentin—epilepsy syndrome	5.03e-05	0.000211	CcSEcCtD
Trandolapril—Chest pain—Gabapentin—epilepsy syndrome	5.03e-05	0.000211	CcSEcCtD
Trandolapril—Nausea—Felbamate—epilepsy syndrome	5.03e-05	0.000211	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	5.02e-05	0.00021	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	5.02e-05	0.000866	CbGpPWpGaD
Trandolapril—Vomiting—Oxcarbazepine—epilepsy syndrome	5.02e-05	0.00021	CcSEcCtD
Trandolapril—Fatigue—Valproic Acid—epilepsy syndrome	5.01e-05	0.00021	CcSEcCtD
Trandolapril—Anxiety—Gabapentin—epilepsy syndrome	5.01e-05	0.00021	CcSEcCtD
Trandolapril—Anorexia—Pregabalin—epilepsy syndrome	5.01e-05	0.00021	CcSEcCtD
Trandolapril—Dizziness—Carbamazepine—epilepsy syndrome	5.01e-05	0.00021	CcSEcCtD
Trandolapril—Diarrhoea—Lamotrigine—epilepsy syndrome	5.01e-05	0.00021	CcSEcCtD
Trandolapril—Headache—Clonazepam—epilepsy syndrome	5e-05	0.00021	CcSEcCtD
Trandolapril—Rash—Phenytoin—epilepsy syndrome	5e-05	0.000209	CcSEcCtD
Trandolapril—Mental disorder—Topiramate—epilepsy syndrome	5e-05	0.000209	CcSEcCtD
Trandolapril—Dermatitis—Phenytoin—epilepsy syndrome	5e-05	0.000209	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	4.99e-05	0.000209	CcSEcCtD
Trandolapril—Rash—Oxcarbazepine—epilepsy syndrome	4.97e-05	0.000208	CcSEcCtD
Trandolapril—Constipation—Valproic Acid—epilepsy syndrome	4.97e-05	0.000208	CcSEcCtD
Trandolapril—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.97e-05	0.000208	CcSEcCtD
Trandolapril—Headache—Phenytoin—epilepsy syndrome	4.97e-05	0.000208	CcSEcCtD
Trandolapril—Malnutrition—Topiramate—epilepsy syndrome	4.97e-05	0.000208	CcSEcCtD
Trandolapril—Discomfort—Gabapentin—epilepsy syndrome	4.97e-05	0.000208	CcSEcCtD
Trandolapril—Headache—Oxcarbazepine—epilepsy syndrome	4.94e-05	0.000207	CcSEcCtD
Trandolapril—Nausea—Zonisamide—epilepsy syndrome	4.92e-05	0.000206	CcSEcCtD
Trandolapril—Dry mouth—Gabapentin—epilepsy syndrome	4.92e-05	0.000206	CcSEcCtD
Trandolapril—Hypotension—Pregabalin—epilepsy syndrome	4.91e-05	0.000206	CcSEcCtD
Trandolapril—Flatulence—Topiramate—epilepsy syndrome	4.9e-05	0.000205	CcSEcCtD
Trandolapril—Dysgeusia—Topiramate—epilepsy syndrome	4.86e-05	0.000204	CcSEcCtD
Trandolapril—Dizziness—Lamotrigine—epilepsy syndrome	4.84e-05	0.000203	CcSEcCtD
Trandolapril—Oedema—Gabapentin—epilepsy syndrome	4.82e-05	0.000202	CcSEcCtD
Trandolapril—Vomiting—Carbamazepine—epilepsy syndrome	4.81e-05	0.000202	CcSEcCtD
Trandolapril—Back pain—Topiramate—epilepsy syndrome	4.81e-05	0.000201	CcSEcCtD
Trandolapril—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.79e-05	0.000201	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.79e-05	0.000201	CcSEcCtD
Trandolapril—Infection—Gabapentin—epilepsy syndrome	4.79e-05	0.000201	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	4.78e-05	0.000826	CbGpPWpGaD
Trandolapril—Muscle spasms—Topiramate—epilepsy syndrome	4.78e-05	0.0002	CcSEcCtD
Trandolapril—Rash—Carbamazepine—epilepsy syndrome	4.77e-05	0.0002	CcSEcCtD
Trandolapril—Dermatitis—Carbamazepine—epilepsy syndrome	4.77e-05	0.0002	CcSEcCtD
Trandolapril—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.75e-05	0.000199	CcSEcCtD
Trandolapril—Insomnia—Pregabalin—epilepsy syndrome	4.75e-05	0.000199	CcSEcCtD
Trandolapril—Nausea—Clonazepam—epilepsy syndrome	4.74e-05	0.000199	CcSEcCtD
Trandolapril—Headache—Carbamazepine—epilepsy syndrome	4.74e-05	0.000199	CcSEcCtD
Trandolapril—Shock—Gabapentin—epilepsy syndrome	4.74e-05	0.000199	CcSEcCtD
Trandolapril—Nervous system disorder—Gabapentin—epilepsy syndrome	4.73e-05	0.000198	CcSEcCtD
Trandolapril—Paraesthesia—Pregabalin—epilepsy syndrome	4.72e-05	0.000198	CcSEcCtD
Trandolapril—Thrombocytopenia—Gabapentin—epilepsy syndrome	4.72e-05	0.000198	CcSEcCtD
Trandolapril—Nausea—Phenytoin—epilepsy syndrome	4.71e-05	0.000197	CcSEcCtD
Trandolapril—Tachycardia—Gabapentin—epilepsy syndrome	4.7e-05	0.000197	CcSEcCtD
Trandolapril—Dyspnoea—Pregabalin—epilepsy syndrome	4.69e-05	0.000196	CcSEcCtD
Trandolapril—Nausea—Oxcarbazepine—epilepsy syndrome	4.69e-05	0.000196	CcSEcCtD
Trandolapril—Skin disorder—Gabapentin—epilepsy syndrome	4.68e-05	0.000196	CcSEcCtD
Trandolapril—Somnolence—Pregabalin—epilepsy syndrome	4.67e-05	0.000196	CcSEcCtD
Trandolapril—Hyperhidrosis—Gabapentin—epilepsy syndrome	4.66e-05	0.000195	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	4.65e-05	0.000803	CbGpPWpGaD
Trandolapril—Vomiting—Lamotrigine—epilepsy syndrome	4.65e-05	0.000195	CcSEcCtD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	4.65e-05	0.000803	CbGpPWpGaD
Trandolapril—Urticaria—Valproic Acid—epilepsy syndrome	4.62e-05	0.000193	CcSEcCtD
Trandolapril—Rash—Lamotrigine—epilepsy syndrome	4.61e-05	0.000193	CcSEcCtD
Trandolapril—Ill-defined disorder—Topiramate—epilepsy syndrome	4.61e-05	0.000193	CcSEcCtD
Trandolapril—Dermatitis—Lamotrigine—epilepsy syndrome	4.61e-05	0.000193	CcSEcCtD
Trandolapril—Abdominal pain—Valproic Acid—epilepsy syndrome	4.6e-05	0.000193	CcSEcCtD
Trandolapril—Body temperature increased—Valproic Acid—epilepsy syndrome	4.6e-05	0.000193	CcSEcCtD
Trandolapril—Anorexia—Gabapentin—epilepsy syndrome	4.59e-05	0.000192	CcSEcCtD
Trandolapril—Anaemia—Topiramate—epilepsy syndrome	4.59e-05	0.000192	CcSEcCtD
Trandolapril—Headache—Lamotrigine—epilepsy syndrome	4.58e-05	0.000192	CcSEcCtD
Trandolapril—Decreased appetite—Pregabalin—epilepsy syndrome	4.57e-05	0.000191	CcSEcCtD
Trandolapril—Agitation—Topiramate—epilepsy syndrome	4.57e-05	0.000191	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	4.54e-05	0.00019	CcSEcCtD
Trandolapril—Fatigue—Pregabalin—epilepsy syndrome	4.53e-05	0.00019	CcSEcCtD
Trandolapril—Hypotension—Gabapentin—epilepsy syndrome	4.5e-05	0.000189	CcSEcCtD
Trandolapril—Nausea—Carbamazepine—epilepsy syndrome	4.5e-05	0.000188	CcSEcCtD
Trandolapril—Constipation—Pregabalin—epilepsy syndrome	4.49e-05	0.000188	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—AGT—epilepsy syndrome	4.48e-05	0.000774	CbGpPWpGaD
Trandolapril—Malaise—Topiramate—epilepsy syndrome	4.48e-05	0.000188	CcSEcCtD
Trandolapril—Vertigo—Topiramate—epilepsy syndrome	4.46e-05	0.000187	CcSEcCtD
Trandolapril—Syncope—Topiramate—epilepsy syndrome	4.46e-05	0.000187	CcSEcCtD
Trandolapril—Leukopenia—Topiramate—epilepsy syndrome	4.45e-05	0.000186	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	4.44e-05	0.000766	CbGpPWpGaD
Trandolapril—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	4.39e-05	0.000184	CcSEcCtD
Trandolapril—Palpitations—Topiramate—epilepsy syndrome	4.39e-05	0.000184	CcSEcCtD
Trandolapril—Loss of consciousness—Topiramate—epilepsy syndrome	4.37e-05	0.000183	CcSEcCtD
Trandolapril—Insomnia—Gabapentin—epilepsy syndrome	4.36e-05	0.000183	CcSEcCtD
Trandolapril—Nausea—Lamotrigine—epilepsy syndrome	4.35e-05	0.000182	CcSEcCtD
Trandolapril—Cough—Topiramate—epilepsy syndrome	4.34e-05	0.000182	CcSEcCtD
Trandolapril—Feeling abnormal—Pregabalin—epilepsy syndrome	4.33e-05	0.000181	CcSEcCtD
Trandolapril—Paraesthesia—Gabapentin—epilepsy syndrome	4.33e-05	0.000181	CcSEcCtD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	4.32e-05	0.000745	CbGpPWpGaD
Trandolapril—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.3e-05	0.00018	CcSEcCtD
Trandolapril—Dyspnoea—Gabapentin—epilepsy syndrome	4.3e-05	0.00018	CcSEcCtD
Trandolapril—Somnolence—Gabapentin—epilepsy syndrome	4.28e-05	0.000179	CcSEcCtD
Trandolapril—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.28e-05	0.000179	CcSEcCtD
Trandolapril—Dyspepsia—Gabapentin—epilepsy syndrome	4.24e-05	0.000178	CcSEcCtD
Trandolapril—Chest pain—Topiramate—epilepsy syndrome	4.23e-05	0.000177	CcSEcCtD
Trandolapril—Arthralgia—Topiramate—epilepsy syndrome	4.23e-05	0.000177	CcSEcCtD
Trandolapril—Myalgia—Topiramate—epilepsy syndrome	4.23e-05	0.000177	CcSEcCtD
Trandolapril—Anxiety—Topiramate—epilepsy syndrome	4.21e-05	0.000177	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	4.2e-05	0.000176	CcSEcCtD
Trandolapril—Decreased appetite—Gabapentin—epilepsy syndrome	4.19e-05	0.000176	CcSEcCtD
Trandolapril—Discomfort—Topiramate—epilepsy syndrome	4.18e-05	0.000175	CcSEcCtD
Trandolapril—Urticaria—Pregabalin—epilepsy syndrome	4.18e-05	0.000175	CcSEcCtD
Trandolapril—Asthenia—Valproic Acid—epilepsy syndrome	4.17e-05	0.000175	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	4.16e-05	0.000174	CcSEcCtD
Trandolapril—Fatigue—Gabapentin—epilepsy syndrome	4.15e-05	0.000174	CcSEcCtD
Trandolapril—Abdominal pain—Pregabalin—epilepsy syndrome	4.15e-05	0.000174	CcSEcCtD
Trandolapril—Body temperature increased—Pregabalin—epilepsy syndrome	4.15e-05	0.000174	CcSEcCtD
Trandolapril—Dry mouth—Topiramate—epilepsy syndrome	4.14e-05	0.000173	CcSEcCtD
Trandolapril—Constipation—Gabapentin—epilepsy syndrome	4.12e-05	0.000173	CcSEcCtD
Trandolapril—Pruritus—Valproic Acid—epilepsy syndrome	4.11e-05	0.000172	CcSEcCtD
Trandolapril—Oedema—Topiramate—epilepsy syndrome	4.05e-05	0.00017	CcSEcCtD
Trandolapril—Infection—Topiramate—epilepsy syndrome	4.03e-05	0.000169	CcSEcCtD
Trandolapril—Shock—Topiramate—epilepsy syndrome	3.99e-05	0.000167	CcSEcCtD
Trandolapril—Diarrhoea—Valproic Acid—epilepsy syndrome	3.98e-05	0.000167	CcSEcCtD
Trandolapril—Nervous system disorder—Topiramate—epilepsy syndrome	3.98e-05	0.000167	CcSEcCtD
Trandolapril—Feeling abnormal—Gabapentin—epilepsy syndrome	3.97e-05	0.000166	CcSEcCtD
Trandolapril—Thrombocytopenia—Topiramate—epilepsy syndrome	3.97e-05	0.000166	CcSEcCtD
Trandolapril—Tachycardia—Topiramate—epilepsy syndrome	3.96e-05	0.000166	CcSEcCtD
Trandolapril—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.94e-05	0.000165	CcSEcCtD
Trandolapril—Skin disorder—Topiramate—epilepsy syndrome	3.94e-05	0.000165	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.94e-05	0.000679	CbGpPWpGaD
Trandolapril—Hyperhidrosis—Topiramate—epilepsy syndrome	3.92e-05	0.000164	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.9e-05	0.000673	CbGpPWpGaD
Trandolapril—Hypersensitivity—Pregabalin—epilepsy syndrome	3.87e-05	0.000162	CcSEcCtD
Trandolapril—Anorexia—Topiramate—epilepsy syndrome	3.86e-05	0.000162	CcSEcCtD
Trandolapril—Dizziness—Valproic Acid—epilepsy syndrome	3.84e-05	0.000161	CcSEcCtD
Trandolapril—Urticaria—Gabapentin—epilepsy syndrome	3.83e-05	0.00016	CcSEcCtD
Trandolapril—Body temperature increased—Gabapentin—epilepsy syndrome	3.81e-05	0.00016	CcSEcCtD
Trandolapril—Abdominal pain—Gabapentin—epilepsy syndrome	3.81e-05	0.00016	CcSEcCtD
Trandolapril—Hypotension—Topiramate—epilepsy syndrome	3.79e-05	0.000159	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	3.78e-05	0.000652	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—POMC—epilepsy syndrome	3.77e-05	0.000651	CbGpPWpGaD
Trandolapril—Asthenia—Pregabalin—epilepsy syndrome	3.77e-05	0.000158	CcSEcCtD
Trandolapril—Pruritus—Pregabalin—epilepsy syndrome	3.72e-05	0.000156	CcSEcCtD
Trandolapril—Vomiting—Valproic Acid—epilepsy syndrome	3.7e-05	0.000155	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.69e-05	0.000155	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—CCL2—epilepsy syndrome	3.69e-05	0.000637	CbGpPWpGaD
Trandolapril—Insomnia—Topiramate—epilepsy syndrome	3.67e-05	0.000154	CcSEcCtD
Trandolapril—Rash—Valproic Acid—epilepsy syndrome	3.67e-05	0.000154	CcSEcCtD
Trandolapril—Dermatitis—Valproic Acid—epilepsy syndrome	3.66e-05	0.000153	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.65e-05	0.00063	CbGpPWpGaD
Trandolapril—Headache—Valproic Acid—epilepsy syndrome	3.64e-05	0.000153	CcSEcCtD
Trandolapril—Paraesthesia—Topiramate—epilepsy syndrome	3.64e-05	0.000153	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.62e-05	0.000625	CbGpPWpGaD
Trandolapril—Dyspnoea—Topiramate—epilepsy syndrome	3.61e-05	0.000151	CcSEcCtD
Trandolapril—Somnolence—Topiramate—epilepsy syndrome	3.6e-05	0.000151	CcSEcCtD
Trandolapril—Diarrhoea—Pregabalin—epilepsy syndrome	3.6e-05	0.000151	CcSEcCtD
Trandolapril—Dyspepsia—Topiramate—epilepsy syndrome	3.57e-05	0.00015	CcSEcCtD
Trandolapril—Hypersensitivity—Gabapentin—epilepsy syndrome	3.55e-05	0.000149	CcSEcCtD
Trandolapril—Decreased appetite—Topiramate—epilepsy syndrome	3.52e-05	0.000148	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	3.51e-05	0.000605	CbGpPWpGaD
Trandolapril—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.5e-05	0.000147	CcSEcCtD
Trandolapril—Fatigue—Topiramate—epilepsy syndrome	3.5e-05	0.000146	CcSEcCtD
Trandolapril—Dizziness—Pregabalin—epilepsy syndrome	3.48e-05	0.000146	CcSEcCtD
Trandolapril—Constipation—Topiramate—epilepsy syndrome	3.47e-05	0.000145	CcSEcCtD
Trandolapril—Asthenia—Gabapentin—epilepsy syndrome	3.46e-05	0.000145	CcSEcCtD
Trandolapril—Nausea—Valproic Acid—epilepsy syndrome	3.45e-05	0.000145	CcSEcCtD
Trandolapril—Pruritus—Gabapentin—epilepsy syndrome	3.41e-05	0.000143	CcSEcCtD
Trandolapril—Vomiting—Pregabalin—epilepsy syndrome	3.34e-05	0.00014	CcSEcCtD
Trandolapril—Feeling abnormal—Topiramate—epilepsy syndrome	3.34e-05	0.00014	CcSEcCtD
Trandolapril—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.32e-05	0.000139	CcSEcCtD
Trandolapril—Rash—Pregabalin—epilepsy syndrome	3.31e-05	0.000139	CcSEcCtD
Trandolapril—Dermatitis—Pregabalin—epilepsy syndrome	3.31e-05	0.000139	CcSEcCtD
Trandolapril—Diarrhoea—Gabapentin—epilepsy syndrome	3.3e-05	0.000138	CcSEcCtD
Trandolapril—Headache—Pregabalin—epilepsy syndrome	3.29e-05	0.000138	CcSEcCtD
Trandolapril—Urticaria—Topiramate—epilepsy syndrome	3.22e-05	0.000135	CcSEcCtD
Trandolapril—Body temperature increased—Topiramate—epilepsy syndrome	3.21e-05	0.000134	CcSEcCtD
Trandolapril—Abdominal pain—Topiramate—epilepsy syndrome	3.21e-05	0.000134	CcSEcCtD
Trandolapril—Dizziness—Gabapentin—epilepsy syndrome	3.19e-05	0.000134	CcSEcCtD
Trandolapril—Nausea—Pregabalin—epilepsy syndrome	3.12e-05	0.000131	CcSEcCtD
Trandolapril—Vomiting—Gabapentin—epilepsy syndrome	3.06e-05	0.000128	CcSEcCtD
Trandolapril—Rash—Gabapentin—epilepsy syndrome	3.04e-05	0.000127	CcSEcCtD
Trandolapril—Dermatitis—Gabapentin—epilepsy syndrome	3.04e-05	0.000127	CcSEcCtD
Trandolapril—Headache—Gabapentin—epilepsy syndrome	3.02e-05	0.000126	CcSEcCtD
Trandolapril—Hypersensitivity—Topiramate—epilepsy syndrome	2.99e-05	0.000125	CcSEcCtD
Trandolapril—Asthenia—Topiramate—epilepsy syndrome	2.91e-05	0.000122	CcSEcCtD
Trandolapril—Pruritus—Topiramate—epilepsy syndrome	2.87e-05	0.00012	CcSEcCtD
Trandolapril—Nausea—Gabapentin—epilepsy syndrome	2.86e-05	0.00012	CcSEcCtD
Trandolapril—Diarrhoea—Topiramate—epilepsy syndrome	2.77e-05	0.000116	CcSEcCtD
Trandolapril—Dizziness—Topiramate—epilepsy syndrome	2.68e-05	0.000112	CcSEcCtD
Trandolapril—Vomiting—Topiramate—epilepsy syndrome	2.58e-05	0.000108	CcSEcCtD
Trandolapril—Rash—Topiramate—epilepsy syndrome	2.56e-05	0.000107	CcSEcCtD
Trandolapril—Dermatitis—Topiramate—epilepsy syndrome	2.55e-05	0.000107	CcSEcCtD
Trandolapril—Headache—Topiramate—epilepsy syndrome	2.54e-05	0.000106	CcSEcCtD
Trandolapril—Nausea—Topiramate—epilepsy syndrome	2.41e-05	0.000101	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.36e-05	0.000408	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.19e-05	0.000378	CbGpPWpGaD
